Search Results for keywords:"Substance Abuse and Mental Health Services Administration"

The Department of Health and Human Services (HHS) has released a notice which informs federal agencies about the laboratories and facilities certified to conduct drug testing using urine and oral fluid as per the Mandatory Guidelines for Federal Workplace Drug Testing Programs. As of now, there are no labs certified for oral fluid testing, but several are certified for urine testing, including those in Canada, which are overseen by the standards of the Department of Transportation (DOT). The list includes details about each certified laboratory and highlights a facility that is withdrawing from the certification program.

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced a meeting for its Center for Mental Health Services National Advisory Council, which will take place on March 18, 2021. The meeting is open to the public and will be held virtually. The agenda includes reviewing minutes from the previous meeting, updates from the CMHS Director, and discussions with SAMHSA's Chief of Staff and the Acting Assistant Secretary for Mental Health and Substance Use. Interested persons can register online to participate and submit comments by March 12, 2021.

The Substance Abuse and Mental Health Services Administration (SAMHSA) is withdrawing a previous notice of funding opportunity (NOFO) for the Women's Behavioral Health Technical Assistance Center and plans to reissue it as the National Women's Behavioral Health Technical Assistance Center. This revised NOFO includes updates to the required activities and criteria used for evaluating applications, ensuring that applicants have the necessary knowledge and capacity to perform the tasks effectively. The withdrawal does not reflect any deficiencies in applications that have already been submitted, and organizations that applied will be notified.

The Substance Abuse and Mental Health Services Administration (SAMHSA) is proposing updates to their application plan for the Mental Health and Substance Use Block Grants for fiscal years 2026-2027. These changes aim to improve clarity, update terminology, and better integrate behavioral health with overall health care. SAMHSA is inviting public comments on whether these information collections are helpful and necessary, and how they might reduce the burden on respondents. The estimated time commitment for these processes is projected to remain the same.

The Department of Health and Human Services (HHS) has issued a notice about laboratories that are currently certified to perform drug testing for federal workplace programs. These laboratories need to meet strict standards, and they can conduct drug tests using urine, but not oral fluid, due to existing guidelines. The notice includes a list of these certified laboratories and testing facilities, noting that no labs are currently certified for oral fluid drug testing. Additionally, the notice specifies that to keep their certification, these labs must undergo regular performance tests and inspections.

The Department of Health and Human Services (HHS) informs federal agencies about laboratories and facilities that are certified to meet specific standards for workplace drug testing. These guidelines cover testing with both urine and oral fluids. However, at present, no laboratories are approved for oral fluid testing, while several are approved for urine testing. Laboratories must pass performance tests and inspections to maintain their certification.

The Department of Health and Human Services (HHS) has released a notice about the laboratories and Instrumented Initial Testing Facilities (IITFs) certified to perform drug testing for federal agencies. These facilities must adhere to strict standards for testing urine and oral fluid specimens under the Mandatory Guidelines for Federal Workplace Drug Testing Programs. Currently, no laboratories are certified for oral fluid drug testing, but several are approved for urine drug testing. A list of these certified facilities is updated monthly, and the details are accessible via the HHS website.

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced that the Drug Testing Advisory Board will hold a web conference on March 2 and 3, 2021. The meeting will be open to the public on March 2 from 10:00 a.m. to 2:00 p.m. EST to discuss drug testing guidelines and other topics. The sessions will be closed to the public on March 2 from 2:15 p.m. to 4:30 p.m. EST and throughout March 3 to discuss sensitive matters. Details about the meeting, including registration and agenda, can be found on SAMHSA's website.

The Substance Abuse and Mental Health Services Administration (SAMHSA), in line with the Paperwork Reduction Act of 1995, invites public comments on its plan to collect data for evaluating the 988 Suicide & Crisis Lifeline and Crisis Services Program. This evaluation aims to improve the quality and effectiveness of crisis care by analyzing the implementation, outcomes, and impact of the 988 Lifeline, which connects people in crisis to essential support services across the U.S. The evaluation consists of system-level, client-level, and impact studies, involving various SAMHSA-funded and related programs. SAMHSA encourages written feedback on the necessity and efficiency of the proposed data collection by January 31, 2025.

The Substance Abuse and Mental Health Services Administration's National Advisory Council (SAMHSA NAC) will hold a public virtual meeting on March 22, 2021, from 1:00 p.m. to 5:00 p.m. (ET). The meeting will cover updates on SAMHSA priorities, new grants, and initiatives, as well as a discussion on national issues in mental health and substance use. Interested persons can submit their views in writing or orally, with written submissions due seven days before the meeting. Details for attending the meeting and submitting comments are available on the SAMHSA website.